Venture Certified
| 기술평가보증기업(기금) | 2010-05-11 ~ 2012-05-10 | 20100103779 | 2010-04-16 |
| 기술평가보증기업(기금) | 2012-06-25 ~ 2014-06-24 | 20120105906 | 2010-04-16 |
| 기술평가보증기업(기금) | 2014-06-25 ~ 2016-06-24 | 20140107934 | 2010-04-16 |
| 벤처투자유형 | 2016-06-25 ~ 2018-06-24 | 20160300278 | 2010-04-16 |
| 벤처투자유형 | 2018-06-25 ~ 2020-06-24 | 20180300384 | 2010-04-16 |
| 벤처투자유형 | 2020-06-25 ~ 2022-06-24 | 20200300577 | 2010-04-16 |
| 벤처투자유형 | 2022-06-25 ~ 2025-06-24 | 20220615010008 | 2010-04-16 |
| 벤처투자유형 | 2025-06-25 ~ 2028-06-24 | 20250527010011 | 2010-04-16 |
Revenue CAGR -90.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.2B | 2.2B | 20.0B |
| Operating Profit | -140.5B | -126.6B | -110.3B |
| Net Profit | -153.4B | -118.2B | -106.8B |
| Total Assets | 192.4B | 254.9B | 351.5B |
| Total Liabilities | 32.4B | 59.5B | 58.7B |
| Total Equity | 160.0B | 195.4B | 292.8B |
Operating Loss: Op. profit -140B
Revenue down 92% YoY
3 Consecutive Years of Net Loss
▼ 98.4%
▼ 18.6%
▼ 2366.9%
▼ 19.8%
▼ 97.7%
| Name | Position | Role |
|---|---|---|
| 성승용 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 강남구",
"ceo_name": "성승용",
"certificate": [
{
"cert_number": "20100103779",
"changes": "",
"disclosure_date": "2010-04-16",
"first_cert_date": "2010-04-16",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2010-05-11 ~ 2012-05-10"
},
{
"cert_number": "20120105906",
"changes": "",
"disclosure_date": "2012-06-25",
"first_cert_date": "2010-04-16",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-06-25 ~ 2014-06-24"
},
{
"cert_number": "20140107934",
"changes": "",
"disclosure_date": "2014-07-02",
"first_cert_date": "2010-04-16",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-06-25 ~ 2016-06-24"
},
{
"cert_number": "20160300278",
"changes": "",
"disclosure_date": "2016-06-09",
"first_cert_date": "2010-04-16",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2016-06-25 ~ 2018-06-24"
},
{
"cert_number": "20180300384",
"changes": "",
"disclosure_date": "2018-05-24",
"first_cert_date": "2010-04-16",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2018-06-25 ~ 2020-06-24"
},
{
"cert_number": "20200300577",
"changes": "",
"disclosure_date": "2020-05-21",
"first_cert_date": "2010-04-16",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2020-06-25 ~ 2022-06-24"
},
{
"cert_number": "20220615010008",
"changes": "",
"disclosure_date": "2022-06-15",
"first_cert_date": "2010-04-16",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2022-06-25 ~ 2025-06-24"
},
{
"cert_number": "20250527010011",
"changes": "",
"disclosure_date": "2025-05-27",
"first_cert_date": "2010-04-16",
"no": "8",
"type": "벤처투자유형",
"valid_period": "2025-06-25 ~ 2028-06-24"
}
],
"company_name": "(주)샤페론",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 11238391000,
"cost_of_sales": 0,
"current_assets": 33732077000,
"current_liabilities": 3876376000,
"gross_profit": 2000000000,
"net_income": -10682790000,
"net_income_bs": -10672727000,
"non_current_assets": 1419183000,
"non_current_liabilities": 1995109000,
"non_operating_expenses": 69542000,
"non_operating_income": 416722000,
"operating_profit": -11029970000,
"revenue": 2000000000,
"sga_expenses": 13029970000,
"total_assets": 35151260000,
"total_equity": 29279775000,
"total_liabilities": 5871485000
},
"2023": {
"capital_stock": 11535516000,
"cost_of_sales": 0,
"current_assets": 20865180000,
"current_liabilities": 3203121000,
"gross_profit": 215251000,
"net_income": -11821216000,
"net_income_bs": -11837088000,
"non_current_assets": 4626844000,
"non_current_liabilities": 2751044000,
"non_operating_expenses": 150573000,
"non_operating_income": 991317000,
"operating_profit": -12661960000,
"revenue": 215251000,
"sga_expenses": 12877211000,
"total_assets": 25492024000,
"total_equity": 19537859000,
"total_liabilities": 5954165000
},
"2024": {
"capital_stock": 15071515000,
"cost_of_sales": 0,
"current_assets": 14753474000,
"current_liabilities": 2070326000,
"gross_profit": 17704000,
"net_income": -15341319000,
"net_income_bs": -15341319000,
"non_current_assets": 4490381000,
"non_current_liabilities": 1173351000,
"non_operating_expenses": 1774487000,
"non_operating_income": 482992000,
"operating_profit": -14049824000,
"revenue": 17704000,
"sga_expenses": 14067528000,
"total_assets": 19243855000,
"total_equity": 16000178000,
"total_liabilities": 3243677000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-10-16"
},
{
"amount": "1,679,956,667",
"changes": "1,679,956,667",
"date": "2020-09-28"
},
{
"amount": "2,240,032,667",
"changes": "2,240,032,667",
"date": "2020-09-28"
},
{
"amount": "4,000,000,000",
"changes": "4,000,000,000",
"date": "2020-09-28"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2020-09-28"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-09-21"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-09-11"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-09-11"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2018-06-15"
},
{
"amount": "4,000,000,000",
"changes": "4,000,000,000",
"date": "2018-06-15"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2018-06-15"
},
{
"amount": "2,999,000,000",
"changes": "2,999,000,000",
"date": "2018-06-15"
},
{
"amount": "3,999,970,000",
"changes": "3,999,970,000",
"date": "2018-06-15"
},
{
"amount": "2,239,978,000",
"changes": "2,239,978,000",
"date": "2018-06-15"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2016-02-05"
}
],
"main_products": "가려움증 치료제",
"phone": "02-6083-****",
"years": [
2024,
2023,
2022
]
}